Literature DB >> 23329831

Alpha thalassemia/mental retardation syndrome X-linked gene product ATRX is required for proper replication restart and cellular resistance to replication stress.

Justin Wai-Chung Leung1, Gargi Ghosal, Wenqi Wang, Xi Shen, Jiadong Wang, Lei Li, Junjie Chen.   

Abstract

Alpha thalassemia/mental retardation syndrome X-linked (ATRX) is a member of the SWI/SNF protein family of DNA-dependent ATPases. It functions as a chromatin remodeler and is classified as an SNF2-like helicase. Here, we showed somatic knock-out of ATRX displayed perturbed S-phase progression as well as hypersensitivity to replication stress. ATRX is recruited to sites of DNA damage, required for efficient checkpoint activation and faithful replication restart. In addition, we identified ATRX as a binding partner of MRE11-RAD50-NBS1 (MRN) complex. Together, these results suggest a non-canonical function of ATRX in guarding genomic stability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329831      PMCID: PMC3585069          DOI: 10.1074/jbc.M112.411603

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.

Authors:  Peter W Lewis; Simon J Elsaesser; Kyung-Min Noh; Sonja C Stadler; C David Allis
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-22       Impact factor: 11.205

2.  The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.

Authors:  Pascal Drané; Khalid Ouararhni; Arnaud Depaux; Muhammad Shuaib; Ali Hamiche
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

3.  Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.

Authors:  Irena Draskovic; Nausica Arnoult; Villier Steiner; Silvia Bacchetti; Patrick Lomonte; Arturo Londoño-Vallejo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

4.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells.

Authors:  Lee H Wong; James D McGhie; Marcus Sim; Melissa A Anderson; Soyeon Ahn; Ross D Hannan; Amee J George; Kylie A Morgan; Jeffrey R Mann; K H Andy Choo
Journal:  Genome Res       Date:  2010-01-28       Impact factor: 9.043

5.  Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair.

Authors:  Eva Petermann; Manuel Luís Orta; Natalia Issaeva; Niklas Schultz; Thomas Helleday
Journal:  Mol Cell       Date:  2010-02-26       Impact factor: 17.970

6.  PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination.

Authors:  Helen E Bryant; Eva Petermann; Niklas Schultz; Ann-Sofie Jemth; Olga Loseva; Natalia Issaeva; Fredrik Johansson; Serena Fernandez; Peter McGlynn; Thomas Helleday
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

7.  Involvement of a chromatin remodeling complex in damage tolerance during DNA replication.

Authors:  Karina B Falbo; Constance Alabert; Yuki Katou; Su Wu; Junhong Han; Tammy Wehr; Jing Xiao; Xiangwei He; Zhiguo Zhang; Yang Shi; Katsu Shirahige; Philippe Pasero; Xuetong Shen
Journal:  Nat Struct Mol Biol       Date:  2009-10-25       Impact factor: 15.369

8.  The annealing helicase HARP protects stalled replication forks.

Authors:  Jingsong Yuan; Gargi Ghosal; Junjie Chen
Journal:  Genes Dev       Date:  2009-09-30       Impact factor: 11.361

9.  The annealing helicase HARP is recruited to DNA repair sites via an interaction with RPA.

Authors:  Timur Yusufzai; Xiangduo Kong; Kyoko Yokomori; James T Kadonaga
Journal:  Genes Dev       Date:  2009-09-30       Impact factor: 11.361

10.  Distinct factors control histone variant H3.3 localization at specific genomic regions.

Authors:  Aaron D Goldberg; Laura A Banaszynski; Kyung-Min Noh; Peter W Lewis; Simon J Elsaesser; Sonja Stadler; Scott Dewell; Martin Law; Xingyi Guo; Xuan Li; Duancheng Wen; Ariane Chapgier; Russell C DeKelver; Jeffrey C Miller; Ya-Li Lee; Elizabeth A Boydston; Michael C Holmes; Philip D Gregory; John M Greally; Shahin Rafii; Chingwen Yang; Peter J Scambler; David Garrick; Richard J Gibbons; Douglas R Higgs; Ileana M Cristea; Fyodor D Urnov; Deyou Zheng; C David Allis
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

View more
  41 in total

Review 1.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

2.  PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.

Authors:  Prashanth Krishna Shastrula; Isabel Sierra; Zhong Deng; Frederick Keeney; James E Hayden; Paul M Lieberman; Susan M Janicki
Journal:  J Cell Sci       Date:  2019-03-26       Impact factor: 5.285

3.  The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.

Authors:  Diu Tt Nguyen; Hsiao Phin J Voon; Barbara Xella; Caroline Scott; David Clynes; Christian Babbs; Helena Ayyub; Jon Kerry; Jacqueline A Sharpe; Jackie A Sloane-Stanley; Sue Butler; Chris A Fisher; Nicki E Gray; Thomas Jenuwein; Douglas R Higgs; Richard J Gibbons
Journal:  EMBO Rep       Date:  2017-05-09       Impact factor: 8.807

Review 4.  Chromatin regulation of DNA damage repair and genome integrity in the central nervous system.

Authors:  Ling Pan; Jay Penney; Li-Huei Tsai
Journal:  J Mol Biol       Date:  2014-08-14       Impact factor: 5.469

5.  Arabidopsis ATRX Modulates H3.3 Occupancy and Fine-Tunes Gene Expression.

Authors:  Céline Duc; Matthias Benoit; Gwénaëlle Détourné; Lauriane Simon; Axel Poulet; Matthieu Jung; Alaguraj Veluchamy; David Latrasse; Samuel Le Goff; Sylviane Cotterell; Christophe Tatout; Moussa Benhamed; Aline V Probst
Journal:  Plant Cell       Date:  2017-07-06       Impact factor: 11.277

6.  The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression.

Authors:  Anne-Charlotte Stilp; Myriam Scherer; Patrick König; Axel Fürstberger; Hans A Kestler; Thomas Stamminger
Journal:  PLoS Pathog       Date:  2022-08-08       Impact factor: 7.464

7.  ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.

Authors:  Carl Koschmann; Anda-Alexandra Calinescu; Felipe J Nunez; Alan Mackay; Janet Fazal-Salom; Daniel Thomas; Flor Mendez; Neha Kamran; Marta Dzaman; Lakshman Mulpuri; Johnathon Krasinkiewicz; Robert Doherty; Rosemary Lemons; Jacqueline A Brosnan-Cashman; Youping Li; Soyeon Roh; Lili Zhao; Henry Appelman; David Ferguson; Vera Gorbunova; Alan Meeker; Chris Jones; Pedro R Lowenstein; Maria G Castro
Journal:  Sci Transl Med       Date:  2016-03-02       Impact factor: 17.956

8.  ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability.

Authors:  Carl Koschmann; Pedro R Lowenstein; Maria G Castro
Journal:  Mol Cell Oncol       Date:  2016-04-27

9.  Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.

Authors:  Maya Raghunandan; Jung Eun Yeo; Ryan Walter; Kai Saito; Adam J Harvey; Stacie Ittershagen; Eun-A Lee; Jihyeon Yang; Maureen E Hoatlin; Anja K Bielinsky; Eric A Hendrickson; Orlando Schärer; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

10.  ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.

Authors:  Fei Li; Zhong Deng; Ling Zhang; Caizhi Wu; Ying Jin; Inah Hwang; Olga Vladimirova; Libo Xu; Lynnie Yang; Bin Lu; Javaraju Dheekollu; Jian-Yi Li; Hua Feng; Jian Hu; Christopher R Vakoc; Haoqiang Ying; Jihye Paik; Paul M Lieberman; Hongwu Zheng
Journal:  EMBO J       Date:  2019-08-27       Impact factor: 14.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.